Tissue-engineering company Engitix has raised $5M in Series A funding. Focused on the research of liver disease, Engitix was founded in 2016 by Walid Al-Akkad and Guiseppe Mazza.
Page 4 of 8
#LondonTech Week in Review: 25/11/18-1/12/18
